Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.270
-0.070 (-1.61%)
At close: Sep 25, 2026, 4:00 PM EDT
4.450
+0.180 (4.22%)
Pre-market: Sep 28, 2026, 4:00 AM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $276.26 million as of September 25, 2026. Its market cap has decreased by -28.00% in one year.
Market Cap
276.26M
Enterprise Value
97.22M
1-Year Change
-28.00%
Ranking
Category
Stock Price
$4.27
ChartMarket Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $276.26M, a decrease of -24.49%. That is a compound annual growth rate of -5.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 276.26M | -34.98% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 285.35M |
| Rocket Pharmaceuticals | 284.87M |
| Clinuvel Pharmaceuticals | 284.03M |
| Fate Therapeutics | 281.58M |
| InflaRx | 278.53M |
| Invivyd | 275.36M |
| Vicore Pharma Holding AB | 272.51M |
| Lexeo Therapeutics | 271.56M |